nifedipine has been researched along with Complications of Diabetes Mellitus in 22 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the impact of treatment on cardiovascular mortality and morbidity, we assessed outcomes in patients with hypertension and diabetes who received co-amilozide or nifedipine in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension." | 9.10 | Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT). ( Brown, M; Castaigne, A; de Leeuw, P; Mancia, G; Palmer, CR; Rosenthal, T; Ruilope, LM; Wagener, G, 2003) |
| "Randomised study of diabetic patients with microalbuminuria treated with perindopril or nifedipine for 12 months and monitored for one or three months after stopping treatment depending on whether they were hypertensive or normotensive." | 9.07 | Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group. ( , 1991) |
| " The Modern Approach to the Treatment of Hypertension (MATH) trial was conducted to determine the efficacy and safety of the new once-daily nifedipine gastrointestinal therapeutic system (GITS) formulation in a large cohort of mild-to-moderate hypertensive patients overall, and to identify specific effects of therapy in the presence of complicating factors such as diabetes and obesity." | 9.06 | Endocrine and renal effects of nifedipine gastrointestinal therapeutic system in patients with essential hypertension. Results of a multicenter trial. The Modern Approach to the Treatment of Hypertension Study Group. ( Bravo, EL; Friedman, CP; Krakoff, LR; Tuck, ML, 1990) |
| "We studied the incidence of oedema 2 weeks following initiation of nifedipine therapy for hypertension in a group of 10 diabetic subjects, and also measured skin blood flow (SBF) with a laser Doppler flowmeter, before and after lowering the foot." | 9.06 | Dependent oedema and attenuation of postural vasoconstriction associated with nifedipine therapy for hypertension in diabetic patients. ( Rayman, G; Tooke, JE; Williams, SA, 1989) |
| "It is generally agreed that short acting calcium channel blockers (CCB) as nifedipine are not safe as the reflex increase in sympathetic activity and thus, their use in hypertension (HTN) is questionable." | 7.73 | Treatment of complicated and uncomplicated hypertension with nifedipine in Palestine. ( Sweileh, WM, 2005) |
| "The results of a case-control study of 300 cataract patients and 609 controls indicate that long-term use of aspirin-like analgesics halves the risk of cataract." | 7.67 | Do aspirin-like analgesics protect against cataract? A case-control study. ( Harding, JJ; van Heyningen, R, 1986) |
| "To investigate the impact of treatment on cardiovascular mortality and morbidity, we assessed outcomes in patients with hypertension and diabetes who received co-amilozide or nifedipine in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension." | 5.10 | Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT). ( Brown, M; Castaigne, A; de Leeuw, P; Mancia, G; Palmer, CR; Rosenthal, T; Ruilope, LM; Wagener, G, 2003) |
| "The effects of nisoldipine and slow release nifedipine on mild to moderate hypertension and glycaemic control were studied in 28 diabetic hypertensives, all except one of whom were non-insulin dependent." | 5.07 | Nifedipine and nisoldipine in hypertensive diabetics. ( Clarke, CW; Kubik, MM, 1991) |
| "Randomised study of diabetic patients with microalbuminuria treated with perindopril or nifedipine for 12 months and monitored for one or three months after stopping treatment depending on whether they were hypertensive or normotensive." | 5.07 | Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group. ( , 1991) |
| " The Modern Approach to the Treatment of Hypertension (MATH) trial was conducted to determine the efficacy and safety of the new once-daily nifedipine gastrointestinal therapeutic system (GITS) formulation in a large cohort of mild-to-moderate hypertensive patients overall, and to identify specific effects of therapy in the presence of complicating factors such as diabetes and obesity." | 5.06 | Endocrine and renal effects of nifedipine gastrointestinal therapeutic system in patients with essential hypertension. Results of a multicenter trial. The Modern Approach to the Treatment of Hypertension Study Group. ( Bravo, EL; Friedman, CP; Krakoff, LR; Tuck, ML, 1990) |
| "We studied the incidence of oedema 2 weeks following initiation of nifedipine therapy for hypertension in a group of 10 diabetic subjects, and also measured skin blood flow (SBF) with a laser Doppler flowmeter, before and after lowering the foot." | 5.06 | Dependent oedema and attenuation of postural vasoconstriction associated with nifedipine therapy for hypertension in diabetic patients. ( Rayman, G; Tooke, JE; Williams, SA, 1989) |
| "It is generally agreed that short acting calcium channel blockers (CCB) as nifedipine are not safe as the reflex increase in sympathetic activity and thus, their use in hypertension (HTN) is questionable." | 3.73 | Treatment of complicated and uncomplicated hypertension with nifedipine in Palestine. ( Sweileh, WM, 2005) |
| "The results of a case-control study of 300 cataract patients and 609 controls indicate that long-term use of aspirin-like analgesics halves the risk of cataract." | 3.67 | Do aspirin-like analgesics protect against cataract? A case-control study. ( Harding, JJ; van Heyningen, R, 1986) |
| "Long-acting nifedipine tablets were given to 47 severely and moderately hypertensive patients with renal insufficiency, cardiovascular, cerebrovascular, and peripheral vascular disease, diabetes mellitus, asthma, and systemic lupus erythematosus." | 3.67 | Long-acting nifedipine in moderate and severe hypertensive patients with serious concomitant diseases. ( Bursztyn, M; Grossman, E; Rosenthal, T, 1985) |
| "Atenolol treatment significantly increased triglyceride levels and decreased the HDL-cholesterol levels after 9 months in both groups." | 2.68 | Comparative effects of atenolol versus nifedipine on serum lipids and other biochemical parameters in diabetic and non-diabetic hypertensive subjects. ( Goyal, RK; Satia, MC; Shukla, ML, 1995) |
| "Nifedipine, a dihydropyridine calcium antagonist, improves endothelial function in patients with hypercholesterolaemia by enhancing nitric oxide (NO) activity, and increases endothelial NO bioavailability by antioxidant mechanisms." | 1.34 | Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus. ( Inami, N; Iwasaka, T; Kimura, Y; Nishikawa, M; Nomura, S; Omoto, S; Shouzu, A, 2007) |
| "Nifedipine was the most frequently prescribed antihypertensive (44." | 1.32 | Inadequate control of blood pressure in Nigerians with diabetes. ( Okoro, EO; Oyejola, BA, 2004) |
| "1." | 1.28 | Pharmacological studies of human erectile tissue: characteristics of spontaneous contractions and alterations in alpha-adrenoceptor responsiveness with age and disease in isolated tissues. ( Christ, GJ; Maayani, S; Melman, A; Valcic, M, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (18.18) | 18.7374 |
| 1990's | 10 (45.45) | 18.2507 |
| 2000's | 6 (27.27) | 29.6817 |
| 2010's | 2 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stojanović, M | 1 |
| Prostran, M | 1 |
| Janković, R | 1 |
| Radenković, M | 1 |
| Kobayashi, N | 1 |
| Ishimitsu, T | 1 |
| Mancia, G | 1 |
| Brown, M | 1 |
| Castaigne, A | 1 |
| de Leeuw, P | 1 |
| Palmer, CR | 1 |
| Rosenthal, T | 2 |
| Wagener, G | 1 |
| Ruilope, LM | 1 |
| Fuchs, FD | 1 |
| Okoro, EO | 1 |
| Oyejola, BA | 1 |
| Sweileh, WM | 1 |
| Nomura, S | 1 |
| Inami, N | 1 |
| Kimura, Y | 1 |
| Omoto, S | 1 |
| Shouzu, A | 1 |
| Nishikawa, M | 1 |
| Iwasaka, T | 1 |
| Io, K | 1 |
| Minatoguchi, S | 1 |
| Nishigaki, K | 1 |
| Ojio, S | 1 |
| Tanaka, T | 1 |
| Segawa, T | 1 |
| Matsuo, H | 1 |
| Watanabe, S | 1 |
| Hattori, A | 1 |
| Ueno, K | 1 |
| Ono, H | 1 |
| Hiei, K | 1 |
| Sato, H | 1 |
| Morita, N | 1 |
| Noda, T | 1 |
| Kato, T | 1 |
| Kawasaki, M | 1 |
| Takemura, G | 1 |
| Fujiwara, H | 1 |
| Cicco, G | 1 |
| Pirrelli, A | 1 |
| Satia, MC | 1 |
| Shukla, ML | 1 |
| Goyal, RK | 1 |
| Motro, M | 1 |
| Shemesh, J | 1 |
| Robles, NR | 1 |
| Gill, J | 1 |
| Fonseca, V | 1 |
| Dandona, P | 1 |
| Jeremy, JY | 1 |
| Christ, GJ | 1 |
| Maayani, S | 1 |
| Valcic, M | 1 |
| Melman, A | 1 |
| Ferder, L | 1 |
| Daccordi, H | 1 |
| Martello, M | 1 |
| Panzalis, M | 1 |
| Inserra, F | 1 |
| Clarke, CW | 1 |
| Kubik, MM | 1 |
| Tuck, ML | 1 |
| Bravo, EL | 1 |
| Krakoff, LR | 1 |
| Friedman, CP | 1 |
| Williams, SA | 1 |
| Rayman, G | 1 |
| Tooke, JE | 1 |
| van Heyningen, R | 1 |
| Harding, JJ | 1 |
| Benaim, ME | 1 |
| Macdonald, G | 1 |
| Bursztyn, M | 1 |
| Grossman, E | 1 |
9 trials available for nifedipine and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT).
Topics: Aged; Amiloride; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiovascular D | 2003 |
Comparative effects of atenolol versus nifedipine on serum lipids and other biochemical parameters in diabetic and non-diabetic hypertensive subjects.
Topics: Aged; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Blood Urea Nitrogen; Creatin | 1995 |
Lisinopril and nifedipine administration inhibits the ex vivo uptake of [45Ca2+] by platelets from hypertensive diabetic patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Platelets; Bucladesine; Calcium; Diabet | 1992 |
Angiotensin converting enzyme inhibitors versus calcium antagonists in the treatment of diabetic hypertensive patients.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Creatinine; Diab | 1992 |
Nifedipine and nisoldipine in hypertensive diabetics.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Diabetes Complications; Diabetes Mellitus; Humans; Hyper | 1991 |
Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group.
Topics: Adolescent; Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diab | 1991 |
Endocrine and renal effects of nifedipine gastrointestinal therapeutic system in patients with essential hypertension. Results of a multicenter trial. The Modern Approach to the Treatment of Hypertension Study Group.
Topics: Aged; Blood Pressure; Diabetes Complications; Electrolytes; Endocrine Glands; Female; Heart Rate; He | 1990 |
Dependent oedema and attenuation of postural vasoconstriction associated with nifedipine therapy for hypertension in diabetic patients.
Topics: Adult; Aged; Clinical Trials as Topic; Diabetes Complications; Edema; Female; Humans; Hypertension; | 1989 |
Effect of nifedipine on carbohydrate metabolism and serum lipoproteins in hypertensive patients with and without diabetes mellitus.
Topics: Adult; Aged; Blood Pressure; Carbohydrate Metabolism; Diabetes Complications; Diabetes Mellitus; Fem | 1987 |
13 other studies available for nifedipine and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Clarification of serotonin-induced effects in peripheral artery disease observed through the femoral artery response in models of diabetes and vascular occlusion: The role of calcium ions.
Topics: Animals; Calcium; Diabetes Complications; Disease Models, Animal; Femoral Artery; Nifedipine; Ouabai | 2017 |
Assessment on antihypertensive effect and safety of nifedipine controlled-release tablet administered at 80 mg/day in practical clinic.
Topics: Adult; Age Factors; Aged; Ambulatory Care Facilities; Amlodipine; Antihypertensive Agents; Blood Pre | 2012 |
May we die twice?
Topics: Amiloride; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Complications | 2003 |
Inadequate control of blood pressure in Nigerians with diabetes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care Facilities; Angiotensin-Converting Enzym | 2004 |
Treatment of complicated and uncomplicated hypertension with nifedipine in Palestine.
Topics: Calcium Channel Blockers; Diabetes Complications; Female; Humans; Hypertension; Male; Middle East; N | 2005 |
Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus.
Topics: Adiponectin; Aged; Biomarkers; Calcium Channel Blockers; Diabetes Complications; Diabetes Mellitus, | 2007 |
Effects of benidipine and some other calcium channel blockers on the prognosis of patients with vasospastic angina. Cohort study with evaluation of the ergonovine coronary spasm induction test.
Topics: Adult; Aged; Aging; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Cohort Studies; Coronary | 2007 |
[Glyco-lipid changes in hypertensive diabetic patients undergoing treatment with nifedipine and captopril].
Topics: Adult; Blood Glucose; Captopril; Cholesterol; Diabetes Complications; Diabetes Mellitus; Follow-Up S | 1993 |
Prevalence of coronary calcification in relation to age, gender and risk factor profile in the insight population.
Topics: Calcinosis; Calcium Channel Blockers; Coronary Angiography; Coronary Disease; Diabetes Complications | 1997 |
[New central agents in the treatment of arterial hypertension].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Adult; Antihyp | 1999 |
Pharmacological studies of human erectile tissue: characteristics of spontaneous contractions and alterations in alpha-adrenoceptor responsiveness with age and disease in isolated tissues.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Do aspirin-like analgesics protect against cataract? A case-control study.
Topics: Acetaminophen; Aged; Analgesics; Aspirin; Cataract; Diabetes Complications; Epidemiologic Methods; F | 1986 |
Long-acting nifedipine in moderate and severe hypertensive patients with serious concomitant diseases.
Topics: Adult; Aged; Angina Pectoris; Asthma; Cerebrovascular Disorders; Diabetes Complications; Edema; Fema | 1985 |